ArticleInternational journal of oncology2022

Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β‑catenin and increases irinotecan sensitivity in colorectal cancer.

Maha Abdulla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.